ESTA Earnings Date: Feb 23, 2027 (Estimated) — Establishment Labs Holdings Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is ESTA's next earnings date?
Establishment Labs Holdings Inc. (ESTA) is expected to report Q4 2026 earnings on Tuesday, February 23, 2027 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.05 on revenue of $76.1M.
How did ESTA do in its last earnings report?
In its most recent report on Oct 29, 2026 (Q3 2026), Establishment Labs Holdings Inc. posted EPS of -$0.35 versus the -$0.26 estimate, a miss of 36.3%. Revenue was $72.0M against a $66.8M estimate. The stock's 1-day post-earnings move was -0.8%.
How much does ESTA stock move after earnings?
ESTA beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 10.5% (up or down) in the day after earnings.
About Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
🤖 AI Earnings Analysis
Establishment Labs’ breast-device business delivered a strong 33% revenue increase to $72M, beating estimates by $5M, but the $0.35 loss missed by $0.09 and a 24.2% operating margin keeps execution concerning.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-29 | Q3 2026 | -0.26 | -0.35 | -36.28% | $72.0M | ❌ Miss | -0.81% | — | — |
| 2026-08-06 | Q2 2026 | -0.34 | -0.39 | -15.78% | $67.5M | ❌ Miss | -13.37% | -17.17% | -20.77% |
| 2026-05-06 | Q1 2026 | -0.36 | -0.45 | -25.00% | $59.9M | ❌ Miss | +5.00% | -2.55% | +7.75% |
| 2026-02-24 | Q4 2025 | -0.22 | -0.09 | +59.09% | $64.6M | ✅ Beat | +6.28% | +1.51% | -22.41% |
| 2025-11-05 | Q3 2025 | -0.52 | -0.38 | +26.92% | $53.8M | ✅ Beat | +22.49% | +38.56% | +43.14% |
| 2025-08-07 | Q2 2025 | -0.55 | -0.57 | -3.64% | $51.3M | ❌ Miss | -13.95% | -8.26% | -6.60% |
| 2025-02-26 | Q4 2024 | -0.66 | -0.98 | -48.48% | $44.5M | ❌ Miss | +17.94% | +20.91% | +12.70% |
| 2024-11-07 | Q3 2024 | -0.61 | -0.59 | +3.28% | $40.2M | ✅ Beat | -3.89% | -22.05% | -10.08% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q2 FY26 · $67.5M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Non-US | 63.4% | $42.8M | — | — | — | — | — |
| UNITED STATES | 36.6% | $24.7M | — | — | — | — | — |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.